司帕沙星治疗耐多药肺结核病人的药效学研究_临床医学论文 关键词】 司帕沙星分散片; 耐药肺结核; 药效学 [gap=993]Key words： Sparfloxacin dispersible tablet (SPLX)； MDR-TB； Pharmacodynamics
基于128个网页-相关网页
耐多药肺结核 MDR-TB ; multidrug resistance tuberculosis ; Miltiple drug Resistant Tuberculosis ; multidrug-resistant pulmonary tuberculosis
耐多药肺结核病 multiple drug resistant pulmonary tuberculosis ; multidrug resistance tuberculosis ; MDR-TB
发病及耐多药肺结核 multidrug-resistant pulmonary tuberculosis ; MDR-PTB
复治耐多药肺结核 retreating multi-drug resistant pulmonary tuberculosis
如果不规范治疗，容易产生耐药肺结核。
If the treatment is not standardized, easy to produce drug-resistant tuberculosis.
肺结核患者应留在居住地完成全程治疗，防止产生耐药肺结核。
TB patients should stay in the residence to complete the whole course of treatment, to prevent the emergence of drug-resistant tuberculosis.
而且，有效治疗复发和耐药肺结核病人的治疗方案没有得到深入研究和优化。
Moreover, the effective treatment of recurrent and drug-resistant tuberculosis patients in the treatment program did not receive in-depth study and optimization.
应用推荐